AI assistant
BIO-TECHNE Corp — Director's Dealing 2022
Aug 9, 2022
30718_dirs_2022-08-09_b24cc1eb-13b9-4c51-956e-013a701bc97e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-07
Reporting Person: Furlow Brenda S. (SVP - General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-26 | Common Stock | G | 1330 | — | Disposed | 6290 | Direct |
| 2021-10-26 | Common Stock | G | 1330 | — | Acquired | 1330 | Indirect |
| 2021-10-26 | Common Stock | G | 1330 | — | Disposed | 4960 | Direct |
| 2021-10-26 | Common Stock | G | 1330 | — | Acquired | 1330 | Indirect |
| 2022-08-07 | Common Stock | M | 1969 | — | Acquired | 6929 | Direct |
| 2022-08-07 | Common Stock | F | 969 | $382.97 | Disposed | 5960 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-07 | Restricted Stock Units | $ | M | 1969 | Disposed | Common Stock (1969) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $108.4900 | 2022-08-07 | Common Stock (921) | 921 | Direct |
| Stock Options (Right to Buy) | $125.0500 | 2024-08-09 | Common Stock (9503) | 9503 | Direct |
| Stock Options (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (7339) | 7339 | Direct |
| Stock Options (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (9786) | 9786 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (9968) | 9968 | Direct |
| Stock Options (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (13290) | 13290 | Direct |
| Restricted Stock Units | $ | Common Stock (1679) | 1679 | Direct | |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (7492) | 7492 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (9990) | 9990 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $372.4400 | 2028-03-01 | Common Stock (10997) | 10997 | Direct |
| Restricted Stock Units | $ | Common Stock (1167) | 1167 | Direct | |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (4560) | 4560 | Direct |
| Stock Options (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (6080) | 6080 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Fully exercisable.
F3: On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
F4: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
F5: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
F7: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F8: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F9: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.